If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
More than 55 companies displayed their latest products and services at the American Society of Echocardiography (ASE) 25th Annual Scientific Sessions June 20-24 in Portland, Ore. The meeting is the largest for cardiovascular ultrasound. Highlights from the show floor included:
Although the fundamental workflow has not changed for treatment planning systems over the years, as technology improves, new features are added to enhance workflow and function.
Cardiac ultrasound technology has advanced to keep up with several trends. These include improved workflow for greater efficiency, expanded use of qualification metrics, expanded use of 3-D echo to speed exam times and improve operator reproducibility, and expanded use of 3-D transesophageal echo (TEE) to aid guidance in the growing area of transcatheter structural heart procedures. Here are a few examples of how the newest technology is addressing these trends.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular imaging technologies, clinical applications, and translational and advanced research topics for molecular imaging professionals — nuclear medicine physicians, scientists, radiologists, cardiologists, pharmacists, technologists, researchers, and others involved and interested in nuclear medicine and molecular imaging and therapy.
DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on ...
June 12, 2014 — Philips Healthcare recently introduced Vereos PET/CT, the first digital PET/CT (positron emission tomography/computed tomography) scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. In addition to Vereos, Philips showcased a selection of molecular imaging solutions designed to deliver high image quality, critical clinical information and greater connectivity.
The radiation therapy market, hit hard in 2009 by the recession, saw a sharp decline in purchasing from which it has slowly recovered. During the last five years the market has been steadily growing, with capital equipment budgets for radiation oncology sites increasing. However, it has only been within the last year that equipment purchases for radiation therapy have leveled out. Purchasing decisions today are driven by two main factors: advancements in technology, including more targeted treatment, multifunctional capabilities and improved patient safety; and the evolving reimbursement model, which weighs patient outcomes and the quality of care delivered more heavily.
As research and development continues to reveal the benefits of medical imaging in healthcare, vendors are steadily improving imaging scanners for added efficiency and workflow. Because advanced visualization technologies are a part of the larger medical imaging discussion, these products are also evolving and growing in response to innovation within medical imaging.
Radiation dose management has come to the forefront of healthcare concerns with both patients and providers advocating for measures that will decrease and manage exposure. Research has shown that medical imaging has doubled the public’s exposure to ionizing radiation since the 1980s, and while this statistic includes fluoroscopy, angiography, mammography and standard X-ray, computed tomography (CT) has contributed the majority of the dose increase.
According to The Medical Diagnostic Ultrasound Market in the USA: Challenges & Opportunities in the New Millennium, 2013 report, the U.S. ultrasound market grew almost 3 percent last year compared to 2012 to reach an all-time high of $1.44 billion.